Cytoskeleton Remodeling-Related Proteins Represent a Specific Salivary Signature in PSC Patients

Cytoskeleton Remodeling-Related Proteins Represent a Specific Salivary Signature in PSC Patients

Primary sclerosing cholangitis (PSC) and Primary biliary cholangitis (PBC) are chronic inflammatory biliary diseases characterized by progressive damage of the bile ducts, resulting in hepatobiliary fibrosis and cirrhosis. Currently, specific biomarkers that allow to distinguish between PSC and PBC...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elisa Ceccherini, Antonio Morlando, Francesco Norelli, Barbara Coco, Massimo Bellini, Maurizia Rossana Brunetto, Antonella Cecchettini, Silvia Rocchiccioli
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Molecules
Subjects:	primary sclerosing cholangitis primary biliary cholangitis saliva proteomics LC-MS/MS cytoskeleton
Online Access:	https://www.mdpi.com/1420-3049/29/23/5783
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Overlap syndrome of seronegative primary biliary cholangitis and small duct primary sclerosing cholangitis: a first case report and literature review
by: Salma Souissi, et al.
Published: (2024-12-01)

Transient elastography for assessing liver fibrosis in autoimmune liver diseases: Excellent performance but limited details: Editorial on “Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis”
by: Kyung-Ah Kim
Published: (2025-01-01)

Challenges in Diagnosing Intrahepatic Cholangiolithiasis in a 39-Year-Old Patient
by: A. K. Guseva, et al.
Published: (2024-12-01)

Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression
by: Alena Laschtowitz, et al.
Published: (2025-03-01)

Relapse of autoimmune diseases after liver transplantation
by: V. E. Syutkin, et al.
Published: (2022-12-01)

Genetically predicted immune cells mediate the association between gut microbiota and autoimmune liver diseases
by: Jikang Zhang, et al.
Published: (2024-12-01)

Treatment response rate and life prognosis at autoimmune liver diseases
by: K. V. Ivashkin, et al.
Published: (2015-10-01)

The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids
by: Corinna Boden, et al.
Published: (2025-04-01)

Cholesterol-modified prognostic nutritional index as an independent prognostic biomarker in primary biliary cholangitis patients
by: Huiling Zhu, et al.
Published: (2025-05-01)

Plane xanthoma
by: Connor A. Sheehan, BA, et al.
Published: (2025-09-01)

Differential MYC Phosphorylation Drives the Divergent Cholangiocyte Response to StressSummary
by: Steven P. O’Hara, et al.
Published: (2025-01-01)

A novel clinical trial for primary sclerosing cholangitis from Asia: All regional endeavors should improve global management of primary sclerosing cholangitis: Editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
by: Atsumasa Komori
Published: (2025-04-01)

Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
by: Woo Hyun Paik, et al.
Published: (2025-04-01)

Peroral Cholangioscopy in the Diagnosis and Treatment of Biliary Strictures
by: M. I. Bykov, et al.
Published: (2023-03-01)

PREGNANCY WITH PRIMARY SCLEROSING CHOLANGITIS
by: E. A. Alexandrova, et al.
Published: (2016-09-01)

Challenges and innovations in primary sclerosing cholangitis clinical trials: Evaluating HK-660S and the path forward: Editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
by: Nilanga Nishad
Published: (2025-04-01)

Characteristic features of ulcerative colitis with concomitant primary sclerosing cholangitis
by: Artur W. Uździcki, et al.
Published: (2021-09-01)

Is AMA M2 a useful serologic test for screening high-risk patients for PBC?: Editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”
by: Nae-Yun Heo
Published: (2025-04-01)

Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study
by: Jihye Lim, et al.
Published: (2025-02-01)

Autoimmune liver damage in patients with primary Sjogren's syndrome associated with anticentromeric antibodies
by: B. D. Chalcev, et al.
Published: (2021-06-01)

Clinical Features, Differential Diagnosis and Treatment of IgG<sub>4</sub>-Related Sclerosing Cholangitis
by: A. K. Guseva, et al.
Published: (2024-04-01)

Elevated long-to-very-long-chain ceramide ratio correlates with disease severity in inflammatory bowel disease and primary sclerosing cholangitis
by: Tanja Elger, et al.
Published: (2025-06-01)

Sepsis like a severe complication of autoimmune liver disease in gastroenterological patients
by: A. A. Yakushev, et al.
Published: (2019-03-01)

Bioinformatics analysis reveals shared molecular pathways for relationship between ulcerative colitis and primary sclerosing cholangitis
by: Pooya Jalali, et al.
Published: (2025-05-01)

Multiomic Sequencing Reveals Distinctive Gene Expression and Epigenetic Alterations Associated With Primary Sclerosing Cholangitis Development in Treatment-Naïve Pediatric Ulcerative Colitis
by: Alejandra Rodriguez-Sosa, et al.
Published: (2025-01-01)

Meta-analysis and systematic review of liver transplantation as an ultimate treatment option for secondary sclerosing cholangitis
by: Eyad Gadour, et al.
Published: (2021-11-01)

Autoimmune sclerosing cholangitis might be triggered by SARS-CoV-2 infection in a child – a case report
by: Katarzyna Zdanowicz, et al.
Published: (2022-05-01)

Impact of liver transplantation on intestinal and systemic inflammation markers in patients with colitis ulcerosa concomitant with primary sclerosing cholangitis
by: Artur W. Uździcki, et al.
Published: (2024-12-01)

Identifying patients with undiagnosed primary biliary cholangitis using a clinical management process
by: Agustin Castiella, et al.
Published: (2025-07-01)

Yellow urticaria revealing overlap syndrome of autoimmune hepatitis and primary biliary cholangitis
by: Sana Toujani, et al.
Published: (2023-03-01)

Histological diagnosis of primary biliary cholangitis in one patient without cholestasis alterations: a case report that escaped guidelines
by: Matteo Biagi, et al.
Published: (2024-01-01)

Liver allograft pathology in the late post-transplant period
by: S. E. Voskanyan, et al.
Published: (2023-09-01)

Childhood sclerosing cholangitis associations in a Tunisian tertiary care hospital: a many-faceted disease
by: Miniar Tfifha, et al.
Published: (2019-12-01)

Case Report: Combined Autoimmune Pancreatitis, Ulcerative Colitis and Sclerosing Cholangitis in 28-y.o. Patient
by: A. R. Khurmatullina, et al.
Published: (2025-02-01)

Choledocholithiasis simulating primary sclerosing cholangitis
by: M. P. Korolyov, et al.
Published: (2017-08-01)

Current status of pharmacotherapy for primary sclerosing cholangitis
by: Hang Yang, et al.
Published: (2025-06-01)

Concomitant Pulmonary and Biliary Manifestations of Ulcerative Colitis: A Case Report
by: Pritee Shrestha, et al.
Published: (2025-01-01)

MK2 Inhibition as a Novel Treatment for Fibrosis in Primary Sclerosing Cholangitis via an IL-22-Dependent Mechanism
by: Cody S. Howe, et al.
Published: (2025-07-01)

Primary Biliary Cholangitis and Seropositive Rheumatoid Arthritis: A Two-Sample Mendelian Randomization Study
by: Deng Z, et al.
Published: (2025-06-01)

Peroxisome Proliferator‐Activated Receptor (PPAR) Agonists for Patients With Primary Biliary Cholangitis With Inadequate Response to Ursodeoxycholic Acid (UDCA): A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Maadeha H. Zaidi, et al.
Published: (2025-06-01)